Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Alburel - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Alburel

Approved

STANDARD

Alburel

Reliance Life Sciences Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 48406004c30b60df
Company: Reliance Life Sciences Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: 48406004c30b60df
Drug Approval Philippines Name: Alburel
Product Name: Alburel
Registration Number: BRP-048
Brand Name: Alburel
Generic Name: Human Albumin
Dosage Form: Solution for Infusion (I.V.)
Dosage Strength: 20% w/v (200 mg/mL)
Manufacturer: Reliance Life Sciences Pvt. Ltd.
Importer: Ambica International Corporation
Distributor: Ambica International Corporation
Issuance Date: 28 June 2024
Expiry Date: 05 April 2030
Pharmacologic Category: Plasma Fraction for Specific Use
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

48406004c30b60df

Type

Standard

Back to Philippines FDA Approvals